Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-05-22
1999-07-06
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549510, A61K 31335
Patent
active
059198150
ABSTRACT:
The invention provides taxanes that are conjugates of cis-docosahexaenoic acid and paclitaxel. The conjugates are useful in treating cancer.
REFERENCES:
patent: 4346085 (1982-08-01), Growdon et al.
patent: 4351831 (1982-09-01), Growdon et al.
patent: 4550109 (1985-10-01), Folkers et al.
patent: 4554272 (1985-11-01), Bock et al.
patent: 4636494 (1987-01-01), Growdon et al.
patent: 4684646 (1987-08-01), Chang et al.
patent: 4814470 (1989-03-01), Colin et al.
patent: 4857653 (1989-08-01), Colin et al.
patent: 4933324 (1990-06-01), Shashoua
patent: 4939174 (1990-07-01), Shashoua
patent: 4968672 (1990-11-01), Jacobson et al.
patent: 5116624 (1992-05-01), Horrobin
patent: 5120760 (1992-06-01), Horrobin
patent: 5141958 (1992-08-01), Crozier-Willi et al.
patent: 5194654 (1993-03-01), Hostetler et al.
patent: 5216023 (1993-06-01), Literati et al.
patent: 5223263 (1993-06-01), Hostetler et al.
patent: 5246726 (1993-09-01), Horrobin et al.
patent: 5250722 (1993-10-01), Bombardelli et al.
patent: 5336684 (1994-08-01), Murray et al.
patent: 5356928 (1994-10-01), Murray et al.
patent: 5362831 (1994-11-01), Mongelli et al.
patent: 5411947 (1995-05-01), Hostetler et al.
patent: 5447936 (1995-09-01), Hausheer et al.
patent: 5453520 (1995-09-01), Bombardelli et al.
patent: 5453521 (1995-09-01), Gaullier et al.
patent: 5468754 (1995-11-01), Hausheer et al.
patent: 5473055 (1995-12-01), Mongelli et al.
patent: 5476954 (1995-12-01), Bourzat et al.
patent: 5484809 (1996-01-01), Hostetler et al.
patent: 5516800 (1996-05-01), Horrobin et al.
patent: 5580556 (1996-12-01), Horrobin
patent: 5580899 (1996-12-01), Mayhew et al.
Anel, B., et al. "Cytotoxicity of Chlorambucil and Chlorambucil-Fatty Acid Conjugates Against Normal Human Peripheral Blood Lymphocytes", Biochem Pharmacol,(1990),40(6):1193-1200. (Abstract).
Oshima, M., et al., "Effects of Docosahexaenoic Acid (DHA) on Intestinal Polyp Development in APC Delta 716 Knockout Mice", Carcinogenesis, (1995), 16(11):2605-2607. (Abstract).
Deutsch, H.F., et al., "Cytotoxic Effects of Daunomycin-Fatty Acid Complexes on Rat Hepatoma", Cancer Res, (1983), 43(6):2668-2672. (Abstract).
Karmali, R.A., et al., "Effect of Omega-3 Fatty Acids on Growth of a Rat Mammary Tumor", J Natl Cancer Inst (1984), 73(2):457-461. (Abstract).
Tinsley, I.J., et al., "Influence of Dietary Fatty Acids on the Incidence of Mammary Tumors in the CH3H Mouse", Cancer Res, (1981), 41(4):1460-1465. (Abstract).
Anel, A., et al., "Increased Cytotoxicity of Polyunsaturated Fatty Acids on Human Tumoral B and T-Cell Lines Compared with Normal Lymphocytes", Leukemia, (1992), 6(7):680-688. (Abstract).
Jenski, L.J., et al., "Docosahexaenoic Acid-Induced Alteration of THY-1 and CD8 Expression on Murine Splenocytes", Biochim Biophys Acta, (1995), 1236(1):39-50. (Abstract).
de Antueno, R.J., et al., "In Vitro Effect of Eicosapentaenoic and Docosahexaenoic Acids on Prostaglandin E2 Synthesis in a Human Lung Carcinoma", Biochem Int, (1989), 19(3):489-496. (Abstract).
Kinsella, J.E., et al., "Effects of Polyunsaturated Fatty Acids on the Efficacy of Antineoplastic Agents Toward L5178Y Lymphoma Cells", Biochem Pharmacol, (1993), 45(9):1881-1887. (Abstract).
Ehringer, W., et al., "A Comparison of the Effects of Linolenic (18:3 Omega 3) and Docosahexaenoic (22:6 Omega 3) Acids on Phospholipid Bilayers", Chem Phys Lipids, (1990), 54(2):79-88. (Abstract).
Guffy, M.M., et al., "Effect of Cellular Fatty Acid Alteration on Adriamycin Sensitivity in Cultured L1210 Murine Leukemia Cells", Cancer Res, (1984), 44(5):1863-1866. (Abstract).
Madhavi, N., et al., "Effect of N-6 and N-3 Fatty Acids on the Survival of Vincristine Sensitive and Resistant Human Cervical Carcinoma Cells In Vitro", Cancer Lett, (1994), 84(1):31-41. (Abstract).
Kinsella, J.E., et al., "Effects of Polyunsaturated Fatty Acids on the Efficacy of Antineoplastic Agents Toward L5178Y Lymphoma Cells", Biochem Pharmacol, (1993,) 45(9):1881-1887. (Abstract).
Begin, M.E., et al., "Differential Killing of Human Carcinoma Cells Supplemented with N-3 and N-6 Polyunsaturated Fatty Acids", J Natl Cancer Inst, (1986), 77(5):1053-1062. (Abstract).
Falconer, J.S., et al., "Effect of Eicosapentaenoic Acid and Other Fatty Acids on the Growth In Vitro of Human Pancreatic Cancer Cell Lines", Br J Cancer, (1994,) 69(5):826-832. (Abstract).
Plumb, J.A., et al., "Effect of Polyunsaturated Fatty Acids on the Drug Sensitivity of Human Tumour Cell Lines Resistant to Either Cisplatin or Doxorubicin", Br J Cancer, (1993), 67(4):728-733. (Abstract).
de Smidt, P.C., et al., "Characteristics of Association of Oleoyl Derivatives of 5-Fluorodeoxy-Uridine and Methotrexate with Low-Density Lipoproteins (LDL)", Pharm Res, (1992), 9(4):565-569. (Abstract).
Zijlistra, J.G., et al., "Influence of Docosahexaenoic Acid In Vitro on Intracellular Adriamycin Concentration in Lymphocytes and Human Adriamycin-Sensitive and Resistant Small-Cell Lung Cancer Cell Lines, and on Cytotoxicity in the Tumor Cell Lines", Int J Cancer, (1987), 40(6):850-856. (Abstract).
Karmali, R., "N-3 Fatty Acids: Biochemical Actions in Cancer", J Nutr Sci Vitaminol (Tokyo), (1992), 148-152. (Abstract).
Chajes, V., et al., "Influence on N-3 Fatty Acids on the Growth of Human Breast Cancer Cells In Vitro: Relationship to Peroxides and Vitamin-E", Breast Cancer Res Treat, (1995), 34(3):199-212. (Abstract).
Minami, M., et al., "Effects of Low-Dose Eicosapentaenoic Acid, Docosahexaenoic Acid and Dietary Fat on the Incidence, Growth and Cell Kinetics of Mammary Carcinomas in Rats", Oncology, (1996), 53(5):398-405. (Abstract).
Burns, C.P., et al., "Effect of Docosahexaenoic Acid on Rate of Differentiation of HL-60 Human Leukemia", Cancer Res, (1989), 49(12):3252-3258. (Abstract).
Pascale, A.W., et al., "Omega-3 Fatty Acid Modification of Membrane Structure and Function. Alteration by Docosahexaenoic Acid of Tumor Cell Sensitivity to Immune Cytolysis", Nutr Cancer, (1993), 19(2):147-157. (Abstract).
Zerouga, M., et al., "Phospholipid Class as a Determinant in Docosahexaenoic Acid's Effect on Tumor Cell Viability", Anticancer Res, (1996), 16(5A):2863-2868. (Abstract).
Jenski, L.J., et al., "Omega-3 Fatty Acid-Containing Liposomes in Cancer Therapy", Proc Soc Exp Biol Med, (1995), 210(3):227-233. (Abstract).
Jenski, L.J., et al., "Omega 3 Fatty Acids Increase Spontaneous Release of Cytosolic Components From Tumor Cells", Lipids, (1991), 26(5):353-358. (Abstract).
Tessier, C., et al., "Docosahexaenoic Acid is a Potent Inhibitor of Rat Uterine Stromal Cell Proliferation", Biochem Biophys Res Commun, (1995), 207(3):1015-1021. (Abstract).
C.S. Swindell et al., "Characterization of the Taxol Structure-Activity Profile for the Locus of the A-Ring Side Chain", Bioorganic & Medicinal Chem. Ltrs., vol.4, No. 12, pp. 1531-1536 (1994).
J.M. Carboni et al., "Synthesis of a Photoaffinity Analog of Taxol as an Approach to Identify the Taxol Binding Site on Microtubules", Journal of Medicinal Chem. (Sep. 8, 1992).
K.C. Nicolaou et al., "Design, Synthesis and Biological Activity of Protaxols", Nature, 364: 464-466 (Jul 29, 1993).
G.I. Georg et al., "The Medicinal Chemistry of Taxol", in "Taxol Science and Applications" ed. Matthew Suffness. Boca Raton: CRC Press, Inc., 1995, pp. 317-375.
W.C. Rose, Preclinical Antitumor Activity of Taxanes, in "Taxol Science and Applications" ed. Matthew Suffness. Boca Raton: CRC Press, Inc., 1995, pp. 317-375.
T. Higuchi et al., "Prodrugs as Novel Drug Delivery Systems", American Chem. Society, ACS Symposium Series, vol. 14, pp. 14-15 (1975).
S. Iwakami et al., "Inhibition of Arachidonate 5-Lipoxygenase by Phenolic Compounds", Chem. Pharm. Bull. (Japan), 34 (9), 3960-3963, 1986.
Y. Makino et al., Chemical Abstracts, vol. 106, No. 12, issue Mar. 23, 1987, "Pharmaceuticals Permeable to Blood-Brain Barrier", p. 363, dated Sep. 10, 1986.
Hesse, G.W. et al., "Uptake in brain and neurophysiological activity of two lipid esters of gamma-aminobutyric acid", Neuropharamacol. 27:637-40 (1988).
Jacob, J.N. et al., "Gamma-aminobutyric acid esters, 3, Synthesis, brain uptake, and pharmacological properties of C
Bradley Matthews O.
Shashoua Victor E.
Swindell Charles S.
Webb Nigel L.
Neuromedica, Inc.
Reamer James H.
LandOfFree
Taxane compounds and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Taxane compounds and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Taxane compounds and compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-899377